Ivan Fedyunin
Directeur/Membre du Conseil chez Melcap Systems Ltd.
Profil
Ivan Fedyunin is currently a Director at BrainQ Technologies Ltd., Melcap Systems Ltd., Broadq Technologies Ltd., Vigorous Solutions Ltd., and Ocular Discovery Ltd.
He previously worked as an Independent Director at Cleveland BioLabs, Inc. from 2018 to 2021, as a Director-Research & Development at Pharmapark LLC from 2014 to 2017, and as the Chief Operating Officer at Promogen-MAT LLC from 2013 to 2017.
Fedyunin received his undergraduate degree from Moscow State University Lomonosov in 2008 and his doctorate from the University of Potsdam in 2012.
Postes actifs de Ivan Fedyunin
| Sociétés | Poste | Début |
|---|---|---|
| Melcap Systems Ltd. | Directeur/Membre du Conseil | - |
| Broadq Technologies Ltd. | Directeur/Membre du Conseil | - |
| Ocular Discovery Ltd. | Directeur/Membre du Conseil | - |
| Vigorous Solutions Ltd. | Directeur/Membre du Conseil | - |
BrainQ Technologies Ltd.
 BrainQ Technologies Ltd. Packaged SoftwareTechnology Services BrainQ Technologies Ltd. develops a detection and non-invasive treatment technology to help patients with paralysis move their limbs. The company was founded by Segal Yaron, Drechsler Yotam, and Shohami Emerita Esther on August 14, 2011 and is headquartered in Jerusalem, Israel. | Directeur/Membre du Conseil | - |
Anciens postes connus de Ivan Fedyunin
| Sociétés | Poste | Fin |
|---|---|---|
| STATERA BIOPHARMA, INC. | Directeur/Membre du Conseil | 27/07/2021 |
Pharmapark LLC
 Pharmapark LLC Pharmaceuticals: MajorHealth Technology Part of Bioprocess Holding, Pharmapark LLC is a privately-owned Russian biopharmaceutical company that specializes in the development, manufacture, and commercialization of biosimilar products. The company is based in Moscow, Russian Federation. The company has a successful track record of performing complete biotechnological drug development through commercial production and has marketed five biosimilar products. Pharmapark also has an in-house pipeline of novel formulations and biosimilars focused on value-adding treatments. | Directeur Technique/Scientifique/R&D | 01/04/2017 |
Promogen-MAT LLC
 Promogen-MAT LLC Medical/Nursing ServicesHealth Services Promogen-MAT LLC operates as a drug development company. The company was founded in 2010 and is headquartered in Moscow, Russian Federation. | Directeur des opérations | 01/04/2017 |
Formation de Ivan Fedyunin
| University of Potsdam | Doctorate Degree |
| Moscow State University Lomonosov | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Cleveland BioLabs, Inc.
 Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY. | Health Technology |
Pharmapark LLC
Pharmapark LLC Pharmaceuticals: MajorHealth Technology Part of Bioprocess Holding, Pharmapark LLC is a privately-owned Russian biopharmaceutical company that specializes in the development, manufacture, and commercialization of biosimilar products. The company is based in Moscow, Russian Federation. The company has a successful track record of performing complete biotechnological drug development through commercial production and has marketed five biosimilar products. Pharmapark also has an in-house pipeline of novel formulations and biosimilars focused on value-adding treatments. | Health Technology |
Promogen-MAT LLC
Promogen-MAT LLC Medical/Nursing ServicesHealth Services Promogen-MAT LLC operates as a drug development company. The company was founded in 2010 and is headquartered in Moscow, Russian Federation. | Health Services |
| Melcap Systems Ltd. | |
| Broadq Technologies Ltd. | |
| Ocular Discovery Ltd. | |
| Vigorous Solutions Ltd. | |
BrainQ Technologies Ltd.
BrainQ Technologies Ltd. Packaged SoftwareTechnology Services BrainQ Technologies Ltd. develops a detection and non-invasive treatment technology to help patients with paralysis move their limbs. The company was founded by Segal Yaron, Drechsler Yotam, and Shohami Emerita Esther on August 14, 2011 and is headquartered in Jerusalem, Israel. | Technology Services |
